Living beyond cancer: survivorship is more than surviving

Mary S McCabe

doi:10.1038/ncpuro0947 | Full Text | PDF (125K)

Limitations and use of PSA velocity in the diagnosis and characterization of prostate cancer

Andrew D Smith and John L Phillips

Measuring PSA velocity to track prostatic pathophysiologic states is appealing for its simplicity, however, much debate continues as to its clinical value in the diagnosis and characterization of prostate cancer. Phillips and Smith discuss the significance of PSA velocity as a diagnostic measure.

doi:10.1038/ncpuro0936 | Full Text | PDF (159K)

Patient anxiety influences prostate cancer treatment decisions

doi:10.1038/ncpuro0920 | Full Text | PDF (103K)

Is surgical outcome for prostate cancer patients associated with a surgeon's experience?

doi:10.1038/ncpuro0921 | Full Text | PDF (103K)

Ageing is associated with poorer ESWL outcomes in patients with renal calculi

doi:10.1038/ncpuro0922 | Full Text | PDF (113K)

B7-H3 expression level predicts prostate cancer progression following surgery

doi:10.1038/ncpuro0923 | Full Text | PDF (104K)

Increased use of ICSI for treatment of infertility other than male-factor infertility

doi:10.1038/ncpuro0924 | Full Text | PDF (114K)

Increased risk of cardiovascular morbidity in men with prostate cancer who receive ADT

doi:10.1038/ncpuro0926 | Full Text | PDF (104K)

Treatment with baclofen improves dysfunctional voiding in women

doi:10.1038/ncpuro0927 | Full Text | PDF (104K)

Testosterone has clinical benefit for postmenopausal hypoactive sexual desire disorder

doi:10.1038/ncpuro0925 | Full Text | PDF (103K)

Chromogranin A predicts development of hormone-refractory prostate cancer

doi:10.1038/ncpuro0928 | Full Text | PDF (103K)

Higher incidence of genitourinary anomalies in girls with congenital adrenal hyperplasia

doi:10.1038/ncpuro0929 | Full Text | PDF (115K)

Deflux^® injection reduces UTI incidence in children with VUR

doi:10.1038/ncpuro0930 | Full Text | PDF (105K)

Sorafenib plus IFN- is superior to single-agent therapy for metastatic RCC

doi:10.1038/ncpuro0931 | Full Text | PDF (105K)

A novel regimen for poor-prognosis or relapsed germ cell tumors

doi:10.1038/ncponc0947 | Full Text | PDF (103K)

Discontinuation of therapy in men with idiopathic hypogonadotropic hypogonadism

doi:10.1038/ncpuro0948 | Full Text | PDF (103K)

Should patients with prostate cancer without bone metastases receive sodium clodronate?

Fred Saad

doi:10.1038/ncpuro0911 | Full Text | PDF (160K)

Is temsirolimus more safe and effective than interferon for the treatment of advanced renal cell carcinoma?

Ali-Reza Golshayan and Ronald M Bukowski

doi:10.1038/ncpuro0915 | Full Text | PDF (169K)

Should patients with high-risk prostate cancer receive 6 months or 3 years of adjuvant androgen suppression therapy?

Seth Strope and David P Wood

doi:10.1038/ncpuro0932 | Full Text | PDF (163K)

Is genitourinary imaging necessary in patients who have microscopic hematuria after trauma?

Bryan B Voelzke and Jack W McAninch

doi:10.1038/ncpuro0919 | Full Text | PDF (159K)

Should physicians use the updated Partin tables to predict pathologic stage in patients with prostate cancer?

Michael W Kattan

doi:10.1038/ncpuro0940 | Full Text | PDF (161K)

A new nomogram for predicting seminal vesicle invasion at radical prostatectomy

Eric A Klein

doi:10.1038/ncpuro0937 | Full Text | PDF (173K)

Organ-sparing treatment for penile cancer

Alberto A Antunes, Marcos F Dall'Oglio and Miguel Srougi

Radical surgery for penile carcinoma produces good cure rates, but severely impacts on patients' quality of life. For a select group of patients, conservative treatments can be a suitable alternative producing good cure rates without such a negative impact on quality of life. In this Review, the different organ-sparing treatments for penile carcinoma are discussed, along with their suitability for patients with cancers of different stages.

doi:10.1038/ncpuro0918 | Full Text | PDF (309K)

Surgery Insight: surgical management of postprostatectomy incontinence—the artificial urinary sphincter and male sling

Craig V Comiter

Following prostatectomy, many men suffer with urinary incontinence. Stress urinary incontinence (SUI) can continue to be bothersome in some men, even after treatment with conservative therapies. In this article the surgical treatments for male SUI are reviewed. The suitability and efficacy of both the artificial urinary sphincter and the more recently introduced male sling are discussed in detail.

doi:10.1038/ncpuro0935 | Full Text | PDF (379K)

Modern management of pheochromocytoma

Sanjay Kasturi, Alexander Kutikov, Thomas J Guzzo, Ariana L Smith and Alan J Wein

This Case Study describes a 55-year-old man with a history of coronary artery disease who was diagnosed with pheochromocytoma of the left adrenal gland. The authors discuss the diagnosis of this patient and his treatment with alpha-blockade therapy combined with phenoxybenzamine before open adrenalectomy.

doi:10.1038/ncpuro0962 | Full Text | PDF (242K)